Key result
DCGAN-augmented ResNet-18 beats ResNet-50 with ~100% accuracy in classifying HCM on CMR.
Why the study?
Hypertrophic cardiomyopathy is a common inherited cardiac disorder with a variable presentation that can complicate timely diagnosis, prompting evaluation of deep-learning approaches for classifying HCM from cardiovascular magnetic resonance images.
Does a DCGAN-augmented ResNet-18 model improve classification accuracy of hypertrophic cardiomyopathy from cardiovascular magnetic resonance images compared to ResNet-50 and a custom CNN?
Observational
No
Does a DCGAN-augmented ResNet-18 model improve classification accuracy of hypertrophic cardiomyopathy from cardiovascular magnetic resonance images compared to ResNet-50 and a custom CNN?
Answers are grounded in this paper and cite their sources.
A comparatively shallow residual network (ResNet-18) combined with transfer learning and DCGAN synthetic augmentation achieved 99.63% image-level accuracy in classifying hypertrophic cardiomyopathy from CMR images, though patient-level and multicenter validation are required before clinical application.
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disorder whose variable presentation can complicate timely diagnosis. This study evaluated deep-learning approaches for classifying HCM from cardiovascular magnetic resonance (CMR) images. A publicly available dataset containing 59,267 CMR images from healthy individuals and patients with HCM was reorganized and supplemented with 2,000 class-balanced synthetic images generated using a deep convolutional generative adversarial network (DCGAN). The resulting dataset was split into training, validation, and test subsets and used to compare a custom convolutional neural network (CNN), ImageNet-pretrained ResNet-18, and ResNet-50 models. Automatic mixed-precision training on an A100 GPU was used to improve computational efficiency. Among the evaluated models, DCGAN-augmented ResNet-18 produced the strongest reported test performance, achieving 99.63% accuracy with a loss of 0.0107, compared with 98.65% accuracy for ResNet-50 and 95.63% for the custom CNN. Mixed-precision optimization reduced training time and memory consumption while improving baseline model performance. These findings suggest that a comparatively shallow residual network can effectively classify HCM-related CMR image patterns when combined with transfer learning and synthetic augmentation. However, the reported results are limited to the study dataset and image-level evaluation; patient-level evaluation, independent multicenter validation, bias assessment, and explainability analysis are necessary before clinical use.
No takes yet. Share an insight, caveat, or question.
Mullan et al. (2026) conducted an observational in Hypertrophic cardiomyopathy. DCGAN-augmented ImageNet-pretrained ResNet-18 vs. ResNet-50 and custom CNN was evaluated on Test classification accuracy for hypertrophic cardiomyopathy on CMR images. DCGAN-augmented ResNet-18 achieved 99.63% test accuracy in classifying hypertrophic cardiomyopathy from CMR images, outperforming ResNet-50 and a custom CNN.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: